Patents by Inventor Friedrich Mayer

Friedrich Mayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070276004
    Abstract: Synergistic combinations of a macrolide T-cell immunomodulator or immunosuppressant such as 33-epichloro-33-desoxyascomycin and an emollient such as dimethicone, glycerol or isostearyl isostearate are provided, which are useful in particular in the treatment of dermatological or mucosal diseases such as dry skin or atopic or contact dermatitis.
    Type: Application
    Filed: April 2, 2004
    Publication date: November 29, 2007
    Inventors: Stefan Hirsch, Friedrich Mayer, Carle Paul, Nabila Sekkat, Carl-Martin Weiss
  • Publication number: 20070021377
    Abstract: Snyergistic combination of a macrolide T-cell immunomodulator or immunosuppressant such as 33-epichloro-33-desoxyascomycin and a ceramide such as ceramide 3, LPC-9S or linoleic acid are provided, which are useful in particular in the treatment of dermatological or mucosal diseases such as atopic or contact dermatitis or dry skin, asteatotic eczema or xerosis.
    Type: Application
    Filed: April 2, 2004
    Publication date: January 25, 2007
    Inventors: Maximilian Grassberger, Stefan Hirsch, Friedrich Mayer, Nabila Sekkat, Anton Stutz
  • Publication number: 20060106003
    Abstract: Synergistic combinations of a macrolide T-cell immunomodulator or immunosuppressant such as 33-epichloro-33-desoxyascomycin and a calciferol or tacalcitol are provided, which are useful in particular in the treatment of dermatological diseases such as atopic dermatitis, acen and psoriasis or of inflammatory bowel disease (IBD).
    Type: Application
    Filed: April 2, 2004
    Publication date: May 18, 2006
    Inventors: Maximillian Grassberger, Stefan Hirsch, Friedrich Mayer, Josef Meingassner, Carle Paul, Nabila Sekkat
  • Publication number: 20060100187
    Abstract: Additive or synergistic combinations of a macrolide T-cell immunomodulator or immunosuppressant such as 33-epichloro-33-desoxyascomycin and a retinoid, such as etretinate, isotretinoin or tazarotene, optionally with a further pharmaceutically active agent, especially an antibacterial, are provided, which are useful in particular in the treatment of dermatological diseases such as eczema, atopic dermatitis, acne, psoriasis, skin aging, sun damage, post-peel erythema and stretch marks.
    Type: Application
    Filed: April 2, 2004
    Publication date: May 11, 2006
    Inventors: Maximilian Grassberger, Stefan Hirsch, Friedrich Mayer, Josef Meingassner, Carle Paul, Nabila Sekkat, Anton Stutz
  • Publication number: 20050013858
    Abstract: The present invention relates to sustained release pharmaceutical composition for oral administration comprising terbinafine.
    Type: Application
    Filed: June 11, 2001
    Publication date: January 20, 2005
    Inventors: Stefan Hirsch, Friedrich Mayer, Carle Paul, Patrice Guitard
  • Patent number: 6385717
    Abstract: A variety of applications do not require a high data throughput. The standardization of the interface in the field of smart cards fixes the processing width at 1 bit. Therefore, it is effective to use a programmable structure which operates with a data width of one bit. A data processing arrangement in the form of a 1-chip implementation with a processing width of 1 bit can be used in chip cards for simple control and automation functions while utilizing serial protocols. This structure features uncomplicated circuitry, a small chip surface area, a wide field of application and a low power consumption.
    Type: Grant
    Filed: August 17, 1999
    Date of Patent: May 7, 2002
    Assignee: U.S. Philips Corporation
    Inventor: Georg-Friedrich Mayer-Lindenberg
  • Patent number: 3985399
    Abstract: Brake lock in a fluid operated braking system is automatically suppressed by a brake diminishing cylinder and piston unit between the master cylinder and at least one wheel brake cylinder. Spring pressure upon the brake diminishing piston is normally over-balanced by a backstop pressure which is monitored by a wheel sensor. When a brake lock is imminent the backstop pressure drops and causes shifting of the brake diminishing piston from a first position in which it connects the main cylinder with the wheel cylinder into a second position in which it disconnects the main cylinder from the wheel cylinder and lowers the fluid pressure in the latter. Timely restoration of the backstop fluid pressure is insured by electrical contact elements disposed on the brake diminishing piston and engageable with complementary electrical contacts on the brake diminishing cylinder and functional to cause increased backstop pressure to be applied.
    Type: Grant
    Filed: August 27, 1975
    Date of Patent: October 12, 1976
    Assignee: Carsec AG
    Inventor: Friedrich Mayer
  • Patent number: D695956
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: December 17, 2013
    Inventors: Frank Friedrich Mayer, Ralph Kraemer